NovaBay Pharmaceuticals to Present at the 7th Annual LD Micro Invitational

By May 30, 2017

EMERYVILLE, Calif. (May 30, 2017) – NovaBay ® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company focusing on commercializing prescription Avenova® lid and lash hygiene for the domestic eye care market, announces that management is scheduled to present a corporate overview at the 7th Annual LD Micro Invitational Conference on Tuesday, June 6, 2017, at 2:00 p.m. Pacific time (5:00 p.m. Eastern time).  The conference is being held at Luxe Sunset Boulevard Hotel in Los Angeles.

A live webcast and replay will be available on the Investors section of the Company’s website at https://novabay.com/investors/events.

About NovaBay Pharmaceuticals, Inc.: Going Beyond Antibiotics®

NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company focusing on commercializing and developing its non-antibiotic anti-infective products to address the unmet therapeutic needs of the global, topical anti-infective market with its two distinct product categories: the NEUTROX® family of products and the AGANOCIDE® compounds. The Neutrox family of products includes AVENOVA® for the eye care market, NEUTROPHASE® for wound care market, and CELLERX® for the aesthetic dermatology market. The Aganocide compounds, still under development, have target applications in the dermatology and urology markets.

Stay informed on NovaBay’s progress:

Download our Mobile InvestorApp from the Apple Store or Google Play
Like us on Facebook
Follow us on Twitter
Connect with NovaBay on LinkedIn
Join us on Google+
Visit NovaBay’s Website

NovaBay Contacts

For NovaBay Avenova purchasing information:
Please Call us toll free: 1-800-890-0329 or email sales@avenova.com
www.Avenova.com

From the Company                      
Thomas J. Paulson
Chief Financial Officer
510-899-8809
Contact Tom

Investor Contact:
LHA
Jody Cain
310-691-7100
Jcain@lhai.com

 

TOP